drugset / Trial / NCT06049693

Iron Prehabilitation in Endometrial Cancer

NCT06049693

Phase 4 Completed 156 enrolled National and Kapodistrian University of Athens
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Endometrial cancer patients often have iron deficiency anemia before surgery, which can be effectively treated with oral iron supplementation. Anemia and blood transfusions have been previously associated with perioperative infectious diseases. In the present study the investigators will evaluate the impact of perioperative iron supplementation on the incidence of perioperative infections.

Timeline

Start
2023-01-01
Primary completion
2024-01-01
Completion
2024-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject FERROUS GLUCONATE ANHYDROUS Small molecule 300 mg

Indications